@article{Lankin_2018,<br/><span class="tab"></span> title={PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases},<br/><span class="tab"></span> volume={90},<br/><span class="tab"></span> ISSN={0040-3660},<br/><span class="tab"></span> url={http://dx.doi.org/10.26442/terarkh201890927-30},<br/><span class="tab"></span> DOI={10.26442/terarkh201890927-30},<br/><span class="tab"></span> number={9},<br/><span class="tab"></span> journal={Terapevticheskii arkhiv},<br/><span class="tab"></span> publisher={LLC Obyedinennaya Redaktsiya},<br/><span class="tab"></span> author={Lankin,<br/><span class="tab"></span> V Z and Tikhaze,<br/><span class="tab"></span> A K and Viigimaa,<br/><span class="tab"></span> M and Chazova,<br/><span class="tab"></span> I E},<br/><span class="tab"></span> year={2018},<br/><span class="tab"></span> month=sep,<br/><span class="tab"></span> pages={27–30} }